A comparison of two planning techniques for radiotherapy of high grade astrocytomas

Clinical Oncology

Volumn 10, Issue 6, 1998, Pages 392-398

  Crosby, T D L ^a   Melcher, A A ^a   Wetherall, S ^a   Brockway, S ^a   Burnet, N G ^a  

^a VELINDRE CANCER CENTRE   (United Kingdom)

Author keywords

High grade astrocytoma; Radiotherapy planning

Indexed keywords

ARTICLE; ASTROCYTOMA; BRAIN RADIATION; CANCER RADIOTHERAPY; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; HUMAN; PRIORITY JOURNAL; TREATMENT PLANNING; TUMOR LOCALIZATION; TUMOR VOLUME;

EID: 0032412193     PISSN: 09366555     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0936-6555(98)80038-1     Document Type: Article

References (24)

1. Brada M, Thomas DGT. Tumours of the brain and spinal cord in adults. In: Peckham M, Pinedo HM, Veronesi U, editors. Oxford textbook of oncology. Oxford: Oxford University Press, 1995:206-394.
2. Karlsson UL, Leibel SA, Wallner K, et al. Brain. In: Perez CA, Brady LW, editors. Principles and practice of radiation oncology. 2nd ed. Philadelphia, PA: Lippincott, 1992:515-52.
3. van der Kogel AJ. Radiobiology of normal tissues. In: Steel GS, editor. Basic clinical radiobiology. London: Edward Arnold, 1993:99-107.
4. Marks JE, Baglan RJ, Prassad SC, et al. Cerebral radio-necrosis: incidence and risk in relation to dose, time, fractionation and volume. Int J Radiat Oncol Biol Phys 1981;7:243-52.
5. Marsa GW, Goffinet DR, Rubinstein LJ, et al. Megavoltage irradiation in the treatment of gliomas of the brain and spinal cord. Cancer 1975;36:1681-9.
6. Gregor A, Cull A, Traynor E, et al. Neuropsychometric evaluation of long term survivors of adult brain tumours: relationship with tumour and treatment parameters. Radiother Oncol 1996;4:55-9.
7. Davies E, Clarke C, Hopkins A. Malignant cerebral glioma. 1: Survival, disability and morbidity after radiotherapy. BMJ 1996;313:1507-12.
8. Gregor A, Cull A. Radiotherapy for malignant glioma; quality as well as quantity of life is important and must be formally assessed. BMJ 1996 313;1500-1.
9. Brada M, Thomas D, Rampling R, et al. Modern radiotherapy can give good quality survival for six months [letter]. BMJ 1997;314:899.
10. Burnet NG, Taylor RE. Modern radiotherapy techniques are needed to spare normal brain tissue [letter]. BMJ 1997;314:900.
11. Lyman JT. Complication probability as assessed from dose-volume histograms. Radiat Rev 1985;(Suppl 8):104.
12. Brada M. Back to the future; radiotherapy in high grade gliomas. Br J Cancer 1989;60:1-4.
13. Spoudeas HA. Endocrine consequences of irradiation for childhood malignancy. In: Tobias JS and Thomas PRM, editors. Current radiation oncology, vol 1. London: Edward Arnold, 1993:137-59.
14. Walker MD, Strick TA, Sheline G. An analysis of dose effect relationship in the radiotherapy of malignant gliomas. Int J Radiat Oncol Biol Phys 1979;5:1725-31.
15. Bleehan NM, Stenning SP on behalf of the Medical Research Council Brain Tumour Working Party. A Medical Research Council trial of two radiotherapy doses in the treatment of grades 3 and 4 astrocytomas. Br J Cancer 1991;64:769-74.
16. Thornton AF, Hegarty TJ, Ten Haken RK, et al. Three-dimensional planning of astrocytomas: a dosimetric study of cerebral irradiation. Int J Radiat Oncol Biol Phys 1991; 20:1309-15.
17. Kelly PJ, Daumas-Duport C, Scheithauer BW, et al. Stereotactic histological correlations of computerised tomography- and magnetic resonance imaging-defined abnormalities in patients with glial neoplasms. Mayo Clin Proc 1987;62:450-9.
18. Liang BC, Thornton AF, Sandier HM, et al. Malignant astrocytomas: focal tumour recurrence after focal external beam radiation therapy. J Neurosurg 1991;75:559-63.
19. DeSchryver A, Greitz T, Forsby N, et al. Localised shaped field radiotherapy of malignant glioblastoma multiforme. Int J Radiat Oncol Biol Phys 1976;1:713-6.
20. Hochberg FH, Pruit A. Assumptions in the radiotherapy of glioblastoma. Neurology 1980;30:907-11.
21. Wallner KE, Galichich JH, Krol G, et al. Patterns of failure following treatment for glioblastoma multiforme and anaplastic astrocytoma. Int J Radiat Oncol Biol Phys 1989;16:1405-9.
22. Garden AS, Maor MH, Alfred Yung WK, et al. Outcome and patterns of failure following limited-volume irradiation for malignant astrocytomas. Radiother Oncol 1991;20:99-110.
23. Leunens G, Menten J, Weltens C, et al. Quality assessment of medical decision making in radiation oncology: variability in target volume delineation for brain tumours. Radiother Oncol 1993;29:169-75.
24. Hanna CL, Slade S, Mason MD, et al. Translating radiotherapy clinical target volumes into planning target volumes for bladder and brain tumour patients. Br J Cancer 1996;74(Suppl XXVIII):36.